Chimera Biotec Overview

  • Founded
  • 2000
  • Status
  • Private
  • Employees
  • 11
  • Latest Deal Type
  • Undetermined
  • Financing Rounds
  • 2

Chimera Biotec General Information


Developer and marketer of ligand-binding assays for pharmacokinetic, pharmacodynamics and biomarker applications. The company primarily focuses on manufacturing conjugates of antibodies and DNA with novel reagents and improved properties. It also provides immunoassay system for ultra sensitive analyte detection.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Emil-Figge-Street. 76 A
  • 44227 Dortmund
  • Germany
+49 0231 0000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Chimera Biotec Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Chimera Biotec‘s full profile, request access.

Request a free trial

Chimera Biotec Patents

Chimera Biotec Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3264087-B1 Method and device for quantification of target molecules Active 27-Jun-2016 0000000000
EP-3264087-A1 Method and device for quantification of target molecules Granted 27-Jun-2016 0000000000 00
US-20170369927-A1 Method and device for quantification of target molecules Pending 27-Jun-2016 0000000000
EP-2189539-B2 Conjugate complexes for analyte detection Active 21-Nov-2008 0000000000
US-8927210-B2 Conjugate complexes for analyte detection Active 21-Nov-2008 C12Q1/6804 00
To view Chimera Biotec’s complete patent history, request access »

Chimera Biotec Executive Team (2)

Name Title Board Seat Contact Info
Mark Spengler Chief Executive Officer & Director, Project Management
You’re viewing 1 of 2 executive team members. Get the full list »

Chimera Biotec Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial